-
EP1340508
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1340508
| EP1340508 - Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.07.2005 Database last updated on 24.08.2024 | Most recent event Tooltip | 01.07.2005 | Application deemed to be withdrawn | published on 17.08.2005 [2005/33] | Applicant(s) | For all designated states G.D. Searle LLC. P.O. Box 5110 Chicago Illinois 60680-5110 / US | [N/P] |
| Former [2003/36] | For all designated states G.D. Searle LLC P.O. Box 5110 Chicago, Illinois 60680-5110 / US | Inventor(s) | 01 /
Sikorski, James, A 2313 East Royal Court Des Peres, MO63131 / US | 02 /
Glenn, Kevin, C 509 Princeton Gate Court Chesterfield, MO 63017 / US | [2003/39] | Representative(s) | Albrecht, Thomas, et al Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | [N/P] |
| Former [2003/36] | Albrecht, Thomas, Dr., et al Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15 80539 München / DE | Application number, filing date | 03012143.8 | 17.12.1999 | [2003/36] | Priority number, date | US19980113955P | 23.12.1998 Original published format: US 113955 P | US19990142684P | 07.07.1999 Original published format: US 142684 P | [2003/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1340508 | Date: | 03.09.2003 | Language: | EN | [2003/36] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 14.07.2003 | Classification | IPC: | A61K45/06, A61P9/00 | [2003/36] | CPC: |
A61K31/585 (EP,US);
A61K31/19 (EP,US);
A61K31/195 (EP,US);
A61K31/215 (EP,US);
A61K31/455 (EP,US);
A61K31/55 (EP,US);
A61K31/575 (EP,US);
A61K31/785 (EP,US);
A61K45/06 (EP,US);
A61P3/04 (EP);
A61P3/06 (EP);
A61P9/00 (EP);
A61P9/10 (EP)
(-)
| C-Set: |
A61K31/55, A61K2300/00 (EP,US);
A61K31/55, A61K31/19 (US,EP);
A61K31/55, A61K31/195 (US,EP);
A61K31/55, A61K31/215 (US,EP);
A61K31/55, A61K31/455 (US,EP);
A61K31/575, A61K2300/00 (EP,US);
A61K31/585, A61K2300/00 (EP,US);
A61K31/585, A61K31/55 (EP,US); | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2003/36] | Title | German: | Kombinationen von Cholesteryl-Ester-Transfer-Protein- Inhibitoren und Nicotinsäure-Derivaten für kardiovaskuläre Indikationen | [2003/36] | English: | Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications | [2003/36] | French: | Combinaisons d'inhibiteurs de la protéine de transfert du cholestéryle-ester et de dérivés de l'acide nicotinique utilisées dand le cadre de troubles cardio-vasculaires | [2003/36] | Examination procedure | 25.02.2004 | Examination requested [2004/18] | 30.09.2004 | Despatch of a communication from the examining division (Time limit: M04) | 11.02.2005 | Application deemed to be withdrawn, date of legal effect [2005/33] | 18.03.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2005/33] | Parent application(s) Tooltip | EP99965035.1 / EP1140184 | Fees paid | Renewal fee | 02.06.2003 | Renewal fee patent year 03 | 02.06.2003 | Renewal fee patent year 04 | 29.12.2003 | Renewal fee patent year 05 | 27.12.2004 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]JPH04193836 ; | [A]WO9409774 (MERCK & CO INC [US], et al) [A] 1,2,7,8 * claims 1,6,9 * * page 1, lines 6,7 *; | [A]EP0818197 (BAYER AG [DE]) [A] 1,6-8 * claim 1 ** page 16, lines 7-14 *; | [A] - BANYU PHARM, "Treatment agent for hypercholesterolaemia, hyperlipaemia or arteriosclerosis- contains squalene epoxidase inhibitor and other anti-hyperlipaemic agent.", DATABASE WPI, 1, Derwent World Patents Index, Database accession no. 1992-281671, XP002137557 & JPH04193836 A 19920713 (BANYU PHARM) [A] 1-3,6-8 * abstract * |